Patents Assigned to Immudx, Inc.
  • Method and means for assessment and prediction of risk of subsequent ischemic cardiac events
    Patent number: 4492753
    Abstract: A method and means for determining the risk of future cardiac ischemic events in a patient after a sentinel event in that same patient, wherein levels of acid glycoprotein and CK-MB are monitored relative to predetermined threshold levels, within a prescribed time frame after the sentinel event, and these monitored levels are then correlated with the predicted likelihood of future cardiac ischemic events to classify such cardiac patients into categories of risk.
    Type: Grant
    Filed: October 6, 1982
    Date of Patent: January 8, 1985
    Assignee: Immudx, Inc.
    Inventors: William E. Shell, Michael H. Burnam, Zoltan A. Tokes